The US Department of Agriculture approved the genetically modified purple tomato to extend its shelf life and boost nutritional quality almost 15 years after its development.
According to biochemist Cathie Martin, she and her colleagues at Norfolk Plant Scientists (NPS) have been experimenting with pigment production in flowering plants for over two decades, and they've spent almost 15 months developing the purple tomato.
The NPS has been focusing on anthocyanins, the antioxidant-rich pigments that give blackberries and blueberries their signature shades.
Domesticated tomatoes already have genes to produce anthocyanins, but they are not 'turned on.' By carefully adding two genes, the tomatoes and juice become a rich source of antioxidants, because purple pigments are made in the whole tomato, not just the skins.
While there are already some purple-skinned tomatoes, their pigments mostly stop at the outer layers and don't accumulate in the fruit itself.
The NPS also emphasized that there is increasing evidence to show that antioxidants work much better when consumed within foods.
The USDA Animal and Plant Health Inspection Service (APHIS) reported that the tomato was modified to alter its color and enhance its nutritional quality, adding that the plant is unlikely to pose an increased plant pest risk compared to other cultivated tomatoes.
Nathan Pumplin, the CEO of NPS' US-based commercial business, said they are optimistic that they can begin limited distribution of purple tomatoes in the US by 2023.


NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure 



